Edgewise Therapeutics, Inc.
US ˙ NasdaqGS ˙ US28036F1057

SecurityEWTX / Edgewise Therapeutics, Inc.
InstitutionExodusPoint Capital Management, LP
Latest Disclosed Ownership14,672 shares
Latest Disclosed Value $ 237,980
ExodusPoint Capital Management, LP reports 67.58% decrease in ownership of EWTX / Edgewise Therapeutics, Inc.

On November 14, 2025 - ExodusPoint Capital Management, LP filed a 13F-HR form disclosing ownership of 14,672 shares of Edgewise Therapeutics, Inc. (US:EWTX) valued at $237,980 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 13, 2025 disclosing 45,255 shares of Edgewise Therapeutics, Inc.. The current value of the position is $522,176 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 14,672 -30,583 -67.58 238 0.0024
2025-08-13 2025-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 45,255 45,255 1 0.0052
2024-11-12 2024-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 0 -268,143 -100.00 0 -100.00
2024-08-13 2024-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 268,143 268,143 5 0.0329
2023-11-09 2023-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 0 -138,227 -100.00 0 -100.00
2023-08-11 2023-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 138,227 -3,624 -2.55 1 0.0087
2023-05-11 2023-03-31 13F EDGEWISE THERAPEUTICS COM 28036F105 141,851 23,901 20.26 1 -100.00 0.0078
2023-02-13 2022-12-31 13F EDGEWISE THERAPEUTICS COM 28036F105 117,950 432 0.37 1 -99.91 0.0153
2022-11-10 2022-09-30 13F EDGEWISE THERAPEUTICS COM 28036F105 117,518 57,490 95.77 1,156 141.84 0.0151
2022-08-22 2022-06-30 13F EDGEWISE THERAPEUTICS COM 28036F105 60,028 60,028 478 0.0059
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.